Andy V. Phan

919 total citations
15 papers, 628 citations indexed

About

Andy V. Phan is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Andy V. Phan has authored 15 papers receiving a total of 628 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Molecular Biology and 5 papers in Immunology. Recurrent topics in Andy V. Phan's work include Cancer Immunotherapy and Biomarkers (4 papers), Axon Guidance and Neuronal Signaling (4 papers) and Immune Cell Function and Interaction (3 papers). Andy V. Phan is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), Axon Guidance and Neuronal Signaling (4 papers) and Immune Cell Function and Interaction (3 papers). Andy V. Phan collaborates with scholars based in United States, Canada and France. Andy V. Phan's co-authors include Sana D. Karam, David Raben, Ayman Oweida, Shilpa Bhatia, Benjamin Van Court, Laurel B. Darragh, Eric T. Clambey, Lynn E. Heasley, David C. Binder and Shelby Lennon and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Cancer and Cancer Research.

In The Last Decade

Andy V. Phan

14 papers receiving 622 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andy V. Phan United States	10	405	263	150	110	109	15	628
Axel Lechner Germany	12	435 1.1×	328 1.2×	60 0.4×	135 1.2×	60 0.6×	28	660
Teppei Jinno Japan	10	230 0.6×	132 0.5×	74 0.5×	132 1.2×	72 0.7×	13	451
Ryoji Kitamura Japan	10	167 0.4×	52 0.2×	105 0.7×	207 1.9×	52 0.5×	27	482
Tania Rodríguez‐Santamarta Spain	13	245 0.6×	96 0.4×	109 0.7×	142 1.3×	102 0.9×	30	491
Toshiro Ohbuchi Japan	9	360 0.9×	346 1.3×	92 0.6×	124 1.1×	10 0.1×	21	744
David R. Colnot Netherlands	13	239 0.6×	48 0.2×	94 0.6×	148 1.3×	169 1.6×	25	493
Nickole Russo United States	14	171 0.4×	35 0.1×	65 0.4×	323 2.9×	63 0.6×	16	574
Cara Dubyk United States	9	206 0.5×	35 0.1×	48 0.3×	142 1.3×	86 0.8×	9	387
Angela Queisser Germany	15	180 0.4×	47 0.2×	186 1.2×	240 2.2×	20 0.2×	18	603
David W. Schoppy United States	11	365 0.9×	45 0.2×	95 0.6×	489 4.4×	88 0.8×	22	692

Countries citing papers authored by Andy V. Phan

Since Specialization

Citations

This map shows the geographic impact of Andy V. Phan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andy V. Phan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andy V. Phan more than expected).

Fields of papers citing papers by Andy V. Phan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andy V. Phan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andy V. Phan. The network helps show where Andy V. Phan may publish in the future.

Co-authorship network of co-authors of Andy V. Phan

This figure shows the co-authorship network connecting the top 25 collaborators of Andy V. Phan. A scholar is included among the top collaborators of Andy V. Phan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andy V. Phan. Andy V. Phan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Sigouros, Michael, Andy V. Phan, Max F. Levine, et al.. (2024). Whole-Genome Sequencing Analysis of Male Breast Cancer Unveils Novel Structural Events and Potential Therapeutic Targets. Modern Pathology. 37(4). 100452–100452. 5 indexed citations

Bickett, Thomas E., Michael W. Knitz, Miles Piper, et al.. (2021). Dichotomous effects of cellular expression of STAT3 on tumor growth of HNSCC. Molecular Therapy. 30(3). 1149–1162. 6 indexed citations

Oweida, Ayman, Adam C. Mueller, Miles Piper, et al.. (2020). Response to radiotherapy in pancreatic ductal adenocarcinoma is enhanced by inhibition of myeloid-derived suppressor cells using STAT3 anti-sense oligonucleotide. Cancer Immunology Immunotherapy. 70(4). 989–1000. 27 indexed citations

Bhatia, Shilpa, Sanjana Bukkapatnam, Benjamin Van Court, et al.. (2020). The effects of ephrinB2 signaling on proliferation and invasion in glioblastoma multiforme. Molecular Carcinogenesis. 59(9). 1064–1075. 13 indexed citations

Bhatia, Shilpa, Ayman Oweida, Shelby Lennon, et al.. (2019). Inhibition of EphB4–Ephrin-B2 Signaling Reprograms the Tumor Immune Microenvironment in Head and Neck Cancers. Cancer Research. 79(10). 2722–2735. 38 indexed citations

Oweida, Ayman, Laurel B. Darragh, Andy V. Phan, et al.. (2019). STAT3 Modulation of Regulatory T Cells in Response to Radiation Therapy in Head and Neck Cancer. JNCI Journal of the National Cancer Institute. 111(12). 1339–1349. 116 indexed citations

Lennon, Shelby, Ayman Oweida, Andy V. Phan, et al.. (2019). Pancreatic Tumor Microenvironment Modulation by EphB4-ephrinB2 Inhibition and Radiation Combination. Clinical Cancer Research. 25(11). 3352–3365. 18 indexed citations

Bhatia, Shilpa, Jaspreet Sharma, Sanjana Bukkapatnam, et al.. (2018). Inhibition of EphB4–Ephrin-B2 Signaling Enhances Response to Cetuximab–Radiation Therapy in Head and Neck Cancers. Clinical Cancer Research. 24(18). 4539–4550. 23 indexed citations

Oweida, Ayman, Mohammad K. Hararah, Andy V. Phan, et al.. (2018). Resistance to Radiotherapy and PD-L1 Blockade Is Mediated by TIM-3 Upregulation and Regulatory T-Cell Infiltration. Clinical Cancer Research. 24(21). 5368–5380. 209 indexed citations

10.

Oweida, Ayman, Andy V. Phan, Tyler P. Robin, et al.. (2018). Hypofractionated Radiotherapy Is Superior to Conventional Fractionation in an Orthotopic Model of Anaplastic Thyroid Cancer. Thyroid. 28(6). 739–747. 16 indexed citations

11.

Oweida, Ayman, Mohammad K. Hararah, Andy V. Phan, et al.. (2018). Abstract 2766: Resistance to radiotherapy and PD-L1 blockade is mediated by TIM-3 upregulation in anti-PD-L1 refractory head and neck cancer. Cancer Research. 78(13_Supplement). 2766–2766. 1 indexed citations

12.

Oweida, Ayman, Andy V. Phan, Tyler P. Robin, et al.. (2018). Abstract 4168: Radioresistant anaplastic thyroid cancers display a unique gene signature and respond to hypofractionated radiotherapy. Cancer Research. 78(13_Supplement). 4168–4168.

13.

Phan, Andy V., et al.. (2017). Advancing viral RNA structure prediction: measuring the thermodynamics of pyrimidine-rich internal loops. RNA. 23(5). 770–781. 9 indexed citations

14.

Stokes, William A., Diana Abbott, Andy V. Phan, et al.. (2017). Patterns of Care for Patients With Early-Stage Glottic Cancer Undergoing Definitive Radiation Therapy: A National Cancer Database Analysis. International Journal of Radiation Oncology*Biology*Physics. 98(5). 1014–1021. 23 indexed citations

15.

Robin, Tyler P., Bernard L. Jones, Oren Gordon, et al.. (2017). A comprehensive comparative analysis of treatment modalities for sinonasal malignancies. Cancer. 123(16). 3040–3049. 124 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact